KLOW Blend 80mg (BPC-157 10mg + TB-500 10mg + GHK-Cu 50mg + KPV 10mg)

IRON AMINOS KLOW BLEND 80MG

Research-grade multi-component blend prepared for consistency and clear documentation in professional lab workflows.

Key Features

 

• Total 80mg per vial: BPC-157 10mg + TB-500 10mg + GHK-Cu 50mg + KPV 10mg

• ≥99% purity for reproducible results

• Sterile, sealed glass vial with tamper-evident flip cap

• Lot and batch labeling for traceability

• Signature Iron Aminos red honeycomb label for quick identification

• Diluent not included

 

Specifications

 

• Compounds and amounts:

  • BPC-157 (pentadecapeptide) — 10mg

  • TB-500 (thymosin beta-4 research peptide) — 10mg

  • GHK-Cu (Gly-His-Lys•Cu²⁺ complex) — 50mg

  • KPV (Lys-Pro-Val tripeptide) — 10mg

   

• Form and appearance: Lyophilized powders, white to light blue (GHK-Cu may impart a faint blue hue)

• Purity: ≥99%

• Packaging: Sterile glass vial, flip-off cap

• Storage, lyophilized: Cool, dry, away from light

• Storage, after reconstitution: Refrigerate and use promptly per internal SOP

 

What’s Included

 

• 1 × KLOW Blend 80mg vial (no diluent)

 

Handling

 

Use an appropriate sterile diluent and aseptic technique. Confirm solubility and compatibility for each component before combining. Follow your lab’s SOPs for reconstitution, aliquoting, labeling, and disposal.

Research Snapshot

 

• BPC-157: Preclinical models describe pro-repair signaling with angiogenic support, nitric-oxide pathway modulation, and favorable effects in tendon, ligament, and GI mucosal paradigms.

• TB-500: Investigated for actin-mediated cell migration, angiogenesis, and tissue-repair signaling in cell and animal systems.

• GHK-Cu: Studied for extracellular matrix remodeling, collagen and elastin support, and antioxidant or anti-inflammatory gene programs in skin and wound models.

• KPV: Explored for anti-inflammatory activity, including NF-κB modulation, reduced pro-inflammatory cytokines, and support of epithelial barrier integrity in cell and animal models.

• Blend context: Used in method-development settings where angiogenic, cytoskeletal, ECM, and anti-inflammatory pathways are jointly explored. Synergy is not established and outcomes are protocol dependent.

 

Compliance

 

For research use only. Not for human consumption.

Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.